Global Menstrual Cramps Treatment Market by Treatment (Pain Relievers, Hormonal Therapy, Surgery), by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), by End User (Specialty Centers, Hospitals, Ambulatory Surgical Centers), by Route of Administration (Parenteral, Oral, Implants), by Mode of Prescription (Over the Counter, Prescription) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Menstrual Cramps Treatment Market research report which is segmented by Treatment (Pain Relievers, Hormonal Therapy, Surgery), by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), by End User (Specialty Centers, Hospitals, Ambulatory Surgical Centers), by Route of Administration (Parenteral, Oral, Implants), by Mode of Prescription (Over the Counter, Prescription), By Players/Companies Abbott Laboratories, Focus Consumer Healthcare, Johnson & Johnson, Novartis AG, Alvogen, Sanofi, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Pfizer Inc.”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Menstrual Cramps Treatment Market Research Report |
| By Treatment | Pain Relievers, Hormonal Therapy, Surgery |
| By Type | Primary Dysmenorrhea, Secondary Dysmenorrhea |
| By End User | Specialty Centers, Hospitals, Ambulatory Surgical Centers |
| By Route of Administration | Parenteral, Oral, Implants |
| By Mode of Prescription | Over the Counter, Prescription |
| By Companies | Abbott Laboratories, Focus Consumer Healthcare, Johnson & Johnson, Novartis AG, Alvogen, Sanofi, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Pfizer Inc. |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 209 |
| Number of Tables & Figures | 147 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Menstrual Cramps Treatment Market Report Segments:
The market is segmented by Treatment (Pain Relievers, Hormonal Therapy, Surgery), by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), by End User (Specialty Centers, Hospitals, Ambulatory Surgical Centers), by Route of Administration (Parenteral, Oral, Implants), by Mode of Prescription (Over the Counter, Prescription).
Menstrual Cramps Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Menstrual Cramps Treatment Market
Overview of the regional outlook of the Menstrual Cramps Treatment Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Menstrual Cramps Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Menstrual Cramps Treatment Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Pain Relievers
2. Hormonal Therapy
3. Surgery
7. By Type:1. Primary Dysmenorrhea
2. Secondary Dysmenorrhea
8. By End User:1. Specialty Centers
2. Hospitals
3. Ambulatory Surgical Centers
9. By Route of Administration:1. Parenteral
2. Oral
3. Implants
10. By Mode of Prescription:1. Over the Counter
2. Prescription
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Menstrual Cramps Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Menstrual Cramps Treatment Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Menstrual Cramps Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Menstrual Cramps Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Menstrual Cramps Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Menstrual Cramps Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Menstrual Cramps Treatment Market Size & Forecast, 2018-2028
4.5.1 Menstrual Cramps Treatment Market Size and Y-o-Y Growth
4.5.2 Menstrual Cramps Treatment Market Absolute $ Opportunity
Chapter 5 Global Menstrual Cramps Treatment Market Analysis and Forecast by Treatment
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Treatment
5.1.2 Basis Point Share (BPS) Analysis by Treatment
5.1.3 Absolute $ Opportunity Assessment by Treatment
5.2 Menstrual Cramps Treatment Market Size Forecast by Treatment
5.2.1 Pain Relievers
5.2.2 Hormonal Therapy
5.2.3 Surgery
5.3 Market Attractiveness Analysis by Treatment
Chapter 6 Global Menstrual Cramps Treatment Market Analysis and Forecast by Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Type
6.1.2 Basis Point Share (BPS) Analysis by Type
6.1.3 Absolute $ Opportunity Assessment by Type
6.2 Menstrual Cramps Treatment Market Size Forecast by Type
6.2.1 Primary Dysmenorrhea
6.2.2 Secondary Dysmenorrhea
6.3 Market Attractiveness Analysis by Type
Chapter 7 Global Menstrual Cramps Treatment Market Analysis and Forecast by End User
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by End User
7.1.2 Basis Point Share (BPS) Analysis by End User
7.1.3 Absolute $ Opportunity Assessment by End User
7.2 Menstrual Cramps Treatment Market Size Forecast by End User
7.2.1 Specialty Centers
7.2.2 Hospitals
7.2.3 Ambulatory Surgical Centers
7.3 Market Attractiveness Analysis by End User
Chapter 8 Global Menstrual Cramps Treatment Market Analysis and Forecast by Route of Administration
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Route of Administration
8.1.2 Basis Point Share (BPS) Analysis by Route of Administration
8.1.3 Absolute $ Opportunity Assessment by Route of Administration
8.2 Menstrual Cramps Treatment Market Size Forecast by Route of Administration
8.2.1 Parenteral
8.2.2 Oral
8.2.3 Implants
8.3 Market Attractiveness Analysis by Route of Administration
Chapter 9 Global Menstrual Cramps Treatment Market Analysis and Forecast by Mode of Prescription
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Mode of Prescription
9.1.2 Basis Point Share (BPS) Analysis by Mode of Prescription
9.1.3 Absolute $ Opportunity Assessment by Mode of Prescription
9.2 Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
9.2.1 Over the Counter
9.2.2 Prescription
9.3 Market Attractiveness Analysis by Mode of Prescription
Chapter 10 Global Menstrual Cramps Treatment Market Analysis and Forecast by Region
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Region
10.1.2 Basis Point Share (BPS) Analysis by Region
10.1.3 Absolute $ Opportunity Assessment by Region
10.2 Menstrual Cramps Treatment Market Size Forecast by Region
10.2.1 North America
10.2.2 Europe
10.2.3 Asia Pacific
10.2.4 Latin America
10.2.5 Middle East & Africa (MEA)
10.3 Market Attractiveness Analysis by Region
Chapter 11 Coronavirus Disease (COVID-19) Impact
11.1 Introduction
11.2 Current & Future Impact Analysis
11.3 Economic Impact Analysis
11.4 Government Policies
11.5 Investment Scenario
Chapter 12 North America Menstrual Cramps Treatment Analysis and Forecast
12.1 Introduction
12.2 North America Menstrual Cramps Treatment Market Size Forecast by Country
12.2.1 U.S.
12.2.2 Canada
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 North America Menstrual Cramps Treatment Market Size Forecast by Treatment
12.6.1 Pain Relievers
12.6.2 Hormonal Therapy
12.6.3 Surgery
12.7 Basis Point Share (BPS) Analysis by Treatment
12.8 Absolute $ Opportunity Assessment by Treatment
12.9 Market Attractiveness Analysis by Treatment
12.10 North America Menstrual Cramps Treatment Market Size Forecast by Type
12.10.1 Primary Dysmenorrhea
12.10.2 Secondary Dysmenorrhea
12.11 Basis Point Share (BPS) Analysis by Type
12.12 Absolute $ Opportunity Assessment by Type
12.13 Market Attractiveness Analysis by Type
12.14 North America Menstrual Cramps Treatment Market Size Forecast by End User
12.14.1 Specialty Centers
12.14.2 Hospitals
12.14.3 Ambulatory Surgical Centers
12.15 Basis Point Share (BPS) Analysis by End User
12.16 Absolute $ Opportunity Assessment by End User
12.17 Market Attractiveness Analysis by End User
12.18 North America Menstrual Cramps Treatment Market Size Forecast by Route of Administration
12.18.1 Parenteral
12.18.2 Oral
12.18.3 Implants
12.19 Basis Point Share (BPS) Analysis by Route of Administration
12.20 Absolute $ Opportunity Assessment by Route of Administration
12.21 Market Attractiveness Analysis by Route of Administration
12.22 North America Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
12.22.1 Over the Counter
12.22.2 Prescription
12.23 Basis Point Share (BPS) Analysis by Mode of Prescription
12.24 Absolute $ Opportunity Assessment by Mode of Prescription
12.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 13 Europe Menstrual Cramps Treatment Analysis and Forecast
13.1 Introduction
13.2 Europe Menstrual Cramps Treatment Market Size Forecast by Country
13.2.1 Germany
13.2.2 France
13.2.3 Italy
13.2.4 U.K.
13.2.5 Spain
13.2.6 Russia
13.2.7 Rest of Europe
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Europe Menstrual Cramps Treatment Market Size Forecast by Treatment
13.6.1 Pain Relievers
13.6.2 Hormonal Therapy
13.6.3 Surgery
13.7 Basis Point Share (BPS) Analysis by Treatment
13.8 Absolute $ Opportunity Assessment by Treatment
13.9 Market Attractiveness Analysis by Treatment
13.10 Europe Menstrual Cramps Treatment Market Size Forecast by Type
13.10.1 Primary Dysmenorrhea
13.10.2 Secondary Dysmenorrhea
13.11 Basis Point Share (BPS) Analysis by Type
13.12 Absolute $ Opportunity Assessment by Type
13.13 Market Attractiveness Analysis by Type
13.14 Europe Menstrual Cramps Treatment Market Size Forecast by End User
13.14.1 Specialty Centers
13.14.2 Hospitals
13.14.3 Ambulatory Surgical Centers
13.15 Basis Point Share (BPS) Analysis by End User
13.16 Absolute $ Opportunity Assessment by End User
13.17 Market Attractiveness Analysis by End User
13.18 Europe Menstrual Cramps Treatment Market Size Forecast by Route of Administration
13.18.1 Parenteral
13.18.2 Oral
13.18.3 Implants
13.19 Basis Point Share (BPS) Analysis by Route of Administration
13.20 Absolute $ Opportunity Assessment by Route of Administration
13.21 Market Attractiveness Analysis by Route of Administration
13.22 Europe Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
13.22.1 Over the Counter
13.22.2 Prescription
13.23 Basis Point Share (BPS) Analysis by Mode of Prescription
13.24 Absolute $ Opportunity Assessment by Mode of Prescription
13.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 14 Asia Pacific Menstrual Cramps Treatment Analysis and Forecast
14.1 Introduction
14.2 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Country
14.2.1 China
14.2.2 Japan
14.2.3 South Korea
14.2.4 India
14.2.5 Australia
14.2.6 South East Asia (SEA)
14.2.7 Rest of Asia Pacific (APAC)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Treatment
14.6.1 Pain Relievers
14.6.2 Hormonal Therapy
14.6.3 Surgery
14.7 Basis Point Share (BPS) Analysis by Treatment
14.8 Absolute $ Opportunity Assessment by Treatment
14.9 Market Attractiveness Analysis by Treatment
14.10 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Type
14.10.1 Primary Dysmenorrhea
14.10.2 Secondary Dysmenorrhea
14.11 Basis Point Share (BPS) Analysis by Type
14.12 Absolute $ Opportunity Assessment by Type
14.13 Market Attractiveness Analysis by Type
14.14 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by End User
14.14.1 Specialty Centers
14.14.2 Hospitals
14.14.3 Ambulatory Surgical Centers
14.15 Basis Point Share (BPS) Analysis by End User
14.16 Absolute $ Opportunity Assessment by End User
14.17 Market Attractiveness Analysis by End User
14.18 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Route of Administration
14.18.1 Parenteral
14.18.2 Oral
14.18.3 Implants
14.19 Basis Point Share (BPS) Analysis by Route of Administration
14.20 Absolute $ Opportunity Assessment by Route of Administration
14.21 Market Attractiveness Analysis by Route of Administration
14.22 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
14.22.1 Over the Counter
14.22.2 Prescription
14.23 Basis Point Share (BPS) Analysis by Mode of Prescription
14.24 Absolute $ Opportunity Assessment by Mode of Prescription
14.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 15 Latin America Menstrual Cramps Treatment Analysis and Forecast
15.1 Introduction
15.2 Latin America Menstrual Cramps Treatment Market Size Forecast by Country
15.2.1 Brazil
15.2.2 Mexico
15.2.3 Rest of Latin America (LATAM)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Latin America Menstrual Cramps Treatment Market Size Forecast by Treatment
15.6.1 Pain Relievers
15.6.2 Hormonal Therapy
15.6.3 Surgery
15.7 Basis Point Share (BPS) Analysis by Treatment
15.8 Absolute $ Opportunity Assessment by Treatment
15.9 Market Attractiveness Analysis by Treatment
15.10 Latin America Menstrual Cramps Treatment Market Size Forecast by Type
15.10.1 Primary Dysmenorrhea
15.10.2 Secondary Dysmenorrhea
15.11 Basis Point Share (BPS) Analysis by Type
15.12 Absolute $ Opportunity Assessment by Type
15.13 Market Attractiveness Analysis by Type
15.14 Latin America Menstrual Cramps Treatment Market Size Forecast by End User
15.14.1 Specialty Centers
15.14.2 Hospitals
15.14.3 Ambulatory Surgical Centers
15.15 Basis Point Share (BPS) Analysis by End User
15.16 Absolute $ Opportunity Assessment by End User
15.17 Market Attractiveness Analysis by End User
15.18 Latin America Menstrual Cramps Treatment Market Size Forecast by Route of Administration
15.18.1 Parenteral
15.18.2 Oral
15.18.3 Implants
15.19 Basis Point Share (BPS) Analysis by Route of Administration
15.20 Absolute $ Opportunity Assessment by Route of Administration
15.21 Market Attractiveness Analysis by Route of Administration
15.22 Latin America Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
15.22.1 Over the Counter
15.22.2 Prescription
15.23 Basis Point Share (BPS) Analysis by Mode of Prescription
15.24 Absolute $ Opportunity Assessment by Mode of Prescription
15.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 16 Middle East & Africa (MEA) Menstrual Cramps Treatment Analysis and Forecast
16.1 Introduction
16.2 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Country
16.2.1 Saudi Arabia
16.2.2 South Africa
16.2.3 UAE
16.2.4 Rest of Middle East & Africa (MEA)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Treatment
16.6.1 Pain Relievers
16.6.2 Hormonal Therapy
16.6.3 Surgery
16.7 Basis Point Share (BPS) Analysis by Treatment
16.8 Absolute $ Opportunity Assessment by Treatment
16.9 Market Attractiveness Analysis by Treatment
16.10 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Type
16.10.1 Primary Dysmenorrhea
16.10.2 Secondary Dysmenorrhea
16.11 Basis Point Share (BPS) Analysis by Type
16.12 Absolute $ Opportunity Assessment by Type
16.13 Market Attractiveness Analysis by Type
16.14 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by End User
16.14.1 Specialty Centers
16.14.2 Hospitals
16.14.3 Ambulatory Surgical Centers
16.15 Basis Point Share (BPS) Analysis by End User
16.16 Absolute $ Opportunity Assessment by End User
16.17 Market Attractiveness Analysis by End User
16.18 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Route of Administration
16.18.1 Parenteral
16.18.2 Oral
16.18.3 Implants
16.19 Basis Point Share (BPS) Analysis by Route of Administration
16.20 Absolute $ Opportunity Assessment by Route of Administration
16.21 Market Attractiveness Analysis by Route of Administration
16.22 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
16.22.1 Over the Counter
16.22.2 Prescription
16.23 Basis Point Share (BPS) Analysis by Mode of Prescription
16.24 Absolute $ Opportunity Assessment by Mode of Prescription
16.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 17 Competition Landscape
17.1 Menstrual Cramps Treatment Market: Competitive Dashboard
17.2 Global Menstrual Cramps Treatment Market: Market Share Analysis, 2019
17.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
17.3.1 Abbott Laboratories
17.3.2 Focus Consumer Healthcare
17.3.3 Johnson & Johnson
17.3.4 Novartis AG
17.3.5 Alvogen
17.3.6 Sanofi
17.3.7 Bayer AG
17.3.8 F. Hoffmann-La Roche Ltd.
17.3.9 GlaxoSmithKline Plc
17.3.10 Pfizer Inc.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Menstrual Cramps Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Menstrual Cramps Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Menstrual Cramps Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Menstrual Cramps Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Menstrual Cramps Treatment Market Size & Forecast, 2018-2028
4.5.1 Menstrual Cramps Treatment Market Size and Y-o-Y Growth
4.5.2 Menstrual Cramps Treatment Market Absolute $ Opportunity
Chapter 5 Global Menstrual Cramps Treatment Market Analysis and Forecast by Treatment
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Treatment
5.1.2 Basis Point Share (BPS) Analysis by Treatment
5.1.3 Absolute $ Opportunity Assessment by Treatment
5.2 Menstrual Cramps Treatment Market Size Forecast by Treatment
5.2.1 Pain Relievers
5.2.2 Hormonal Therapy
5.2.3 Surgery
5.3 Market Attractiveness Analysis by Treatment
Chapter 6 Global Menstrual Cramps Treatment Market Analysis and Forecast by Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Type
6.1.2 Basis Point Share (BPS) Analysis by Type
6.1.3 Absolute $ Opportunity Assessment by Type
6.2 Menstrual Cramps Treatment Market Size Forecast by Type
6.2.1 Primary Dysmenorrhea
6.2.2 Secondary Dysmenorrhea
6.3 Market Attractiveness Analysis by Type
Chapter 7 Global Menstrual Cramps Treatment Market Analysis and Forecast by End User
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by End User
7.1.2 Basis Point Share (BPS) Analysis by End User
7.1.3 Absolute $ Opportunity Assessment by End User
7.2 Menstrual Cramps Treatment Market Size Forecast by End User
7.2.1 Specialty Centers
7.2.2 Hospitals
7.2.3 Ambulatory Surgical Centers
7.3 Market Attractiveness Analysis by End User
Chapter 8 Global Menstrual Cramps Treatment Market Analysis and Forecast by Route of Administration
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Route of Administration
8.1.2 Basis Point Share (BPS) Analysis by Route of Administration
8.1.3 Absolute $ Opportunity Assessment by Route of Administration
8.2 Menstrual Cramps Treatment Market Size Forecast by Route of Administration
8.2.1 Parenteral
8.2.2 Oral
8.2.3 Implants
8.3 Market Attractiveness Analysis by Route of Administration
Chapter 9 Global Menstrual Cramps Treatment Market Analysis and Forecast by Mode of Prescription
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Mode of Prescription
9.1.2 Basis Point Share (BPS) Analysis by Mode of Prescription
9.1.3 Absolute $ Opportunity Assessment by Mode of Prescription
9.2 Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
9.2.1 Over the Counter
9.2.2 Prescription
9.3 Market Attractiveness Analysis by Mode of Prescription
Chapter 10 Global Menstrual Cramps Treatment Market Analysis and Forecast by Region
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Region
10.1.2 Basis Point Share (BPS) Analysis by Region
10.1.3 Absolute $ Opportunity Assessment by Region
10.2 Menstrual Cramps Treatment Market Size Forecast by Region
10.2.1 North America
10.2.2 Europe
10.2.3 Asia Pacific
10.2.4 Latin America
10.2.5 Middle East & Africa (MEA)
10.3 Market Attractiveness Analysis by Region
Chapter 11 Coronavirus Disease (COVID-19) Impact
11.1 Introduction
11.2 Current & Future Impact Analysis
11.3 Economic Impact Analysis
11.4 Government Policies
11.5 Investment Scenario
Chapter 12 North America Menstrual Cramps Treatment Analysis and Forecast
12.1 Introduction
12.2 North America Menstrual Cramps Treatment Market Size Forecast by Country
12.2.1 U.S.
12.2.2 Canada
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 North America Menstrual Cramps Treatment Market Size Forecast by Treatment
12.6.1 Pain Relievers
12.6.2 Hormonal Therapy
12.6.3 Surgery
12.7 Basis Point Share (BPS) Analysis by Treatment
12.8 Absolute $ Opportunity Assessment by Treatment
12.9 Market Attractiveness Analysis by Treatment
12.10 North America Menstrual Cramps Treatment Market Size Forecast by Type
12.10.1 Primary Dysmenorrhea
12.10.2 Secondary Dysmenorrhea
12.11 Basis Point Share (BPS) Analysis by Type
12.12 Absolute $ Opportunity Assessment by Type
12.13 Market Attractiveness Analysis by Type
12.14 North America Menstrual Cramps Treatment Market Size Forecast by End User
12.14.1 Specialty Centers
12.14.2 Hospitals
12.14.3 Ambulatory Surgical Centers
12.15 Basis Point Share (BPS) Analysis by End User
12.16 Absolute $ Opportunity Assessment by End User
12.17 Market Attractiveness Analysis by End User
12.18 North America Menstrual Cramps Treatment Market Size Forecast by Route of Administration
12.18.1 Parenteral
12.18.2 Oral
12.18.3 Implants
12.19 Basis Point Share (BPS) Analysis by Route of Administration
12.20 Absolute $ Opportunity Assessment by Route of Administration
12.21 Market Attractiveness Analysis by Route of Administration
12.22 North America Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
12.22.1 Over the Counter
12.22.2 Prescription
12.23 Basis Point Share (BPS) Analysis by Mode of Prescription
12.24 Absolute $ Opportunity Assessment by Mode of Prescription
12.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 13 Europe Menstrual Cramps Treatment Analysis and Forecast
13.1 Introduction
13.2 Europe Menstrual Cramps Treatment Market Size Forecast by Country
13.2.1 Germany
13.2.2 France
13.2.3 Italy
13.2.4 U.K.
13.2.5 Spain
13.2.6 Russia
13.2.7 Rest of Europe
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Europe Menstrual Cramps Treatment Market Size Forecast by Treatment
13.6.1 Pain Relievers
13.6.2 Hormonal Therapy
13.6.3 Surgery
13.7 Basis Point Share (BPS) Analysis by Treatment
13.8 Absolute $ Opportunity Assessment by Treatment
13.9 Market Attractiveness Analysis by Treatment
13.10 Europe Menstrual Cramps Treatment Market Size Forecast by Type
13.10.1 Primary Dysmenorrhea
13.10.2 Secondary Dysmenorrhea
13.11 Basis Point Share (BPS) Analysis by Type
13.12 Absolute $ Opportunity Assessment by Type
13.13 Market Attractiveness Analysis by Type
13.14 Europe Menstrual Cramps Treatment Market Size Forecast by End User
13.14.1 Specialty Centers
13.14.2 Hospitals
13.14.3 Ambulatory Surgical Centers
13.15 Basis Point Share (BPS) Analysis by End User
13.16 Absolute $ Opportunity Assessment by End User
13.17 Market Attractiveness Analysis by End User
13.18 Europe Menstrual Cramps Treatment Market Size Forecast by Route of Administration
13.18.1 Parenteral
13.18.2 Oral
13.18.3 Implants
13.19 Basis Point Share (BPS) Analysis by Route of Administration
13.20 Absolute $ Opportunity Assessment by Route of Administration
13.21 Market Attractiveness Analysis by Route of Administration
13.22 Europe Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
13.22.1 Over the Counter
13.22.2 Prescription
13.23 Basis Point Share (BPS) Analysis by Mode of Prescription
13.24 Absolute $ Opportunity Assessment by Mode of Prescription
13.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 14 Asia Pacific Menstrual Cramps Treatment Analysis and Forecast
14.1 Introduction
14.2 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Country
14.2.1 China
14.2.2 Japan
14.2.3 South Korea
14.2.4 India
14.2.5 Australia
14.2.6 South East Asia (SEA)
14.2.7 Rest of Asia Pacific (APAC)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Treatment
14.6.1 Pain Relievers
14.6.2 Hormonal Therapy
14.6.3 Surgery
14.7 Basis Point Share (BPS) Analysis by Treatment
14.8 Absolute $ Opportunity Assessment by Treatment
14.9 Market Attractiveness Analysis by Treatment
14.10 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Type
14.10.1 Primary Dysmenorrhea
14.10.2 Secondary Dysmenorrhea
14.11 Basis Point Share (BPS) Analysis by Type
14.12 Absolute $ Opportunity Assessment by Type
14.13 Market Attractiveness Analysis by Type
14.14 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by End User
14.14.1 Specialty Centers
14.14.2 Hospitals
14.14.3 Ambulatory Surgical Centers
14.15 Basis Point Share (BPS) Analysis by End User
14.16 Absolute $ Opportunity Assessment by End User
14.17 Market Attractiveness Analysis by End User
14.18 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Route of Administration
14.18.1 Parenteral
14.18.2 Oral
14.18.3 Implants
14.19 Basis Point Share (BPS) Analysis by Route of Administration
14.20 Absolute $ Opportunity Assessment by Route of Administration
14.21 Market Attractiveness Analysis by Route of Administration
14.22 Asia Pacific Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
14.22.1 Over the Counter
14.22.2 Prescription
14.23 Basis Point Share (BPS) Analysis by Mode of Prescription
14.24 Absolute $ Opportunity Assessment by Mode of Prescription
14.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 15 Latin America Menstrual Cramps Treatment Analysis and Forecast
15.1 Introduction
15.2 Latin America Menstrual Cramps Treatment Market Size Forecast by Country
15.2.1 Brazil
15.2.2 Mexico
15.2.3 Rest of Latin America (LATAM)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Latin America Menstrual Cramps Treatment Market Size Forecast by Treatment
15.6.1 Pain Relievers
15.6.2 Hormonal Therapy
15.6.3 Surgery
15.7 Basis Point Share (BPS) Analysis by Treatment
15.8 Absolute $ Opportunity Assessment by Treatment
15.9 Market Attractiveness Analysis by Treatment
15.10 Latin America Menstrual Cramps Treatment Market Size Forecast by Type
15.10.1 Primary Dysmenorrhea
15.10.2 Secondary Dysmenorrhea
15.11 Basis Point Share (BPS) Analysis by Type
15.12 Absolute $ Opportunity Assessment by Type
15.13 Market Attractiveness Analysis by Type
15.14 Latin America Menstrual Cramps Treatment Market Size Forecast by End User
15.14.1 Specialty Centers
15.14.2 Hospitals
15.14.3 Ambulatory Surgical Centers
15.15 Basis Point Share (BPS) Analysis by End User
15.16 Absolute $ Opportunity Assessment by End User
15.17 Market Attractiveness Analysis by End User
15.18 Latin America Menstrual Cramps Treatment Market Size Forecast by Route of Administration
15.18.1 Parenteral
15.18.2 Oral
15.18.3 Implants
15.19 Basis Point Share (BPS) Analysis by Route of Administration
15.20 Absolute $ Opportunity Assessment by Route of Administration
15.21 Market Attractiveness Analysis by Route of Administration
15.22 Latin America Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
15.22.1 Over the Counter
15.22.2 Prescription
15.23 Basis Point Share (BPS) Analysis by Mode of Prescription
15.24 Absolute $ Opportunity Assessment by Mode of Prescription
15.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 16 Middle East & Africa (MEA) Menstrual Cramps Treatment Analysis and Forecast
16.1 Introduction
16.2 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Country
16.2.1 Saudi Arabia
16.2.2 South Africa
16.2.3 UAE
16.2.4 Rest of Middle East & Africa (MEA)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Treatment
16.6.1 Pain Relievers
16.6.2 Hormonal Therapy
16.6.3 Surgery
16.7 Basis Point Share (BPS) Analysis by Treatment
16.8 Absolute $ Opportunity Assessment by Treatment
16.9 Market Attractiveness Analysis by Treatment
16.10 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Type
16.10.1 Primary Dysmenorrhea
16.10.2 Secondary Dysmenorrhea
16.11 Basis Point Share (BPS) Analysis by Type
16.12 Absolute $ Opportunity Assessment by Type
16.13 Market Attractiveness Analysis by Type
16.14 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by End User
16.14.1 Specialty Centers
16.14.2 Hospitals
16.14.3 Ambulatory Surgical Centers
16.15 Basis Point Share (BPS) Analysis by End User
16.16 Absolute $ Opportunity Assessment by End User
16.17 Market Attractiveness Analysis by End User
16.18 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Route of Administration
16.18.1 Parenteral
16.18.2 Oral
16.18.3 Implants
16.19 Basis Point Share (BPS) Analysis by Route of Administration
16.20 Absolute $ Opportunity Assessment by Route of Administration
16.21 Market Attractiveness Analysis by Route of Administration
16.22 Middle East & Africa (MEA) Menstrual Cramps Treatment Market Size Forecast by Mode of Prescription
16.22.1 Over the Counter
16.22.2 Prescription
16.23 Basis Point Share (BPS) Analysis by Mode of Prescription
16.24 Absolute $ Opportunity Assessment by Mode of Prescription
16.25 Market Attractiveness Analysis by Mode of Prescription
Chapter 17 Competition Landscape
17.1 Menstrual Cramps Treatment Market: Competitive Dashboard
17.2 Global Menstrual Cramps Treatment Market: Market Share Analysis, 2019
17.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
17.3.1 Abbott Laboratories
17.3.2 Focus Consumer Healthcare
17.3.3 Johnson & Johnson
17.3.4 Novartis AG
17.3.5 Alvogen
17.3.6 Sanofi
17.3.7 Bayer AG
17.3.8 F. Hoffmann-La Roche Ltd.
17.3.9 GlaxoSmithKline Plc
17.3.10 Pfizer Inc.
Segments Covered in the Report
The global Menstrual Cramps Treatment market has been segmented based on
By Treatment
The global Menstrual Cramps Treatment market has been segmented based on
By Treatment
- Pain Relievers
- Hormonal Therapy
- Surgery
- Primary Dysmenorrhea
- Secondary Dysmenorrhea
- Specialty Centers
- Hospitals
- Ambulatory Surgical Centers
- Parenteral
- Oral
- Implants
- Over the Counter
- Prescription
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Abbott Laboratories
- Focus Consumer Healthcare
- Johnson & Johnson
- Novartis AG
- Alvogen
- Sanofi
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Pfizer Inc.
Our Clients
Related Reports
Some other reports from this category!
